Puck T Pelzer

Datos Biográficos

ID7797239
NOMBREPuck T Pelzer
NOMBRESPuck T
APELLIDOPelzer
FIRMAPELZER P T
AFILIACIONESTuBerculosis Vaccine Initiative
ORCID0000-0003-1648-0304
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Prioritizing countries for TB vaccine readiness research using a global stakeholder-centric approach

    Open AccessMichelle M Gill, Rupali J Limaye et al.ARTICLEPLOS Global Public Health2025

    The promise of new tuberculosis (TB) vaccine candidates prompts the need for research on vaccine demand and health system readiness to help ensure effective and equitable vaccine deployment. We developed an approach to prioritizing countries for TB vaccine readiness research by combining stakeholder preferences, elicited through best-worst scaling (BWS) with an analytical hierarchy process (AHP) framework. We conducted a self-administered electro…

  • Mapping the existing body of knowledge on new and repurposed TB vaccine implementation

    Open AccessJoeri S Buis, Degu Jerene et al.ARTICLEPLOS Global Public Health2024

    There is global consensus on the urgent need for a safe and effective TB vaccine for adults and adolescents to improve global TB control, and encouragingly, several promising candidates have advanced to late-stage trials. Significant gaps remain in understanding the critical factors that will facilitate the successful implementation of new and repurposed TB vaccines in low- and middle-income countries (LMICs), once available. By synthesizing the …

  • Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines

    Open AccessPuck T Pelzer, Janet Seeley et al.ARTICLEPLOS Global Public Health2022

    Recently, two Phase 2B tuberculosis vaccine trials reported positive efficacy results in adolescents and adults. However, experience in vaccinating these age groups is limited. We identified potential implementation strategies for the M72/AS01 E vaccination and BCG-revaccination-like candidates and explored their acceptability and feasibility. We conducted in-depth semi-structured interviews among key decision makers to identify implementation st…

  • Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

    Open AccessSarah van de Berg, S E J van de Berg et al.ARTICLEBMC Public Health2021

    Acceptability and feasibility of the BPaL regimen is high among TB stakeholders in Indonesia, Kyrgyzstan, and Nigeria. The majority is willing to start using BPaL as the standard of care for eligible patients despite country-specific health system constraints